LB Pharmaceuticals

Éric Cohen - Managing Director and Founder of Agile Capital Markets

About the deal

LB Pharmaceuticals, a New-York based biotech, raises $110M series C to develop innovative treatments for schizophrenia.

 

Date 2024
Sector Biotech
Transaction Size $110M
Transaction Type Series C
Localisation US